Sie suchten nach: diphenhydramine (Englisch - Slowenisch)

diphenhydramine
difenilhidramin

50 mg diphenhydramine
50 mg difenhidramina

diphenhydramine* and its salts
difenhidramin* in njegove soli

diphenhydramine (inn) and its salts
difenhidramin (inn) in njegove soli

pre-dosing with diphenhydramine diminished these effects, suggesting that histamine may play a role in this process.
predhodno dajanje difenhidramina je te učinke ublažilo, kar kaže na možno vpletenost histamina v ta proces.

h1 blocker: diphenhydramine (25-50 mg orally or intravenous) or equivalent h1 blocker.
antagonist histaminskih receptorjev h1: difenhidramin (od 25 do 50 mg peroralno ali intravensko) ali enakovreden antagonist histaminskih receptorjev h1.

diphenhydramine is reported to be a weak inhibitor of aldehyde oxidase in rat liver, but its inhibitory effects in human liver are not known.
poročali so, da je difenhidramin šibak zaviralec aldehid oksidaze v jetrih podgan, njegovi zaviralni učinki v človeških jetrih pa niso znani.

patients should be given intravenous diphenhydramine 25 to 50 mg (or similar antihistamine) approximately 30 minutes before the start of each dose of temsirolimus.
2 bolniki naj približno 30 minut pred začetkom vsakega odmerka temsirolimusa intravensko prejmejo 25 do 50 mg difenhidramina (ali podobnega antihistaminika).

antihistamine (dexchlorpheniramine 5 mg or diphenhydramine 25 mg or equivalent), corticosteroid (dexamethasone 8 mg or equivalent), and
antihistaminik (5 mg deksklorfeniramina ali 25 mg difenhidramina ali enakovredni zdravili),

in addition, an oral antihistamine, e. g. diphenhydramine 50 mg, and an analgesic, e. g. paracetamol 500 mg, may be given.
500 mg paracetamola.

oral antipyretics (paracetamol 650 to 1,000 mg), plus oral or intravenous antihistamine (diphenhydramine 25 to 50 mg or equivalent).
peroralni antipiretik (paracetamol v odmerku 650 do 1.000 mg) in peroralni ali intravenski antihistaminik (difenhidramin v odmerku 25 do 50 mg ali drugo enakovredno zdravilo).

for subsequent cycles, premedication with an h1 antagonist (e.g., diphenhydramine) should be given intravenously 30–60 minutes prior to each dose of olaratumab.
pri vseh nadaljnjih ciklih je potrebna ponovna intravenska premedikacija z antagonistom h1 (npr. difenhidraminom) od 30 do 60 minut pred vsakim odmerkom olaratumaba.

based on the published literature, in vitro studies of binding to human serum proteins, using paclitaxel at concentrations ranging from 0.03 to 1.2 µm, indicate that about 87% of paclitaxel is bound; the presence of ranitidine, dexamethasone, or diphenhydramine did not affect protein binding of paclitaxel.
prisotnost ranitidina, deksametazona ali difenhidramina ni vplivala na vezavo paklitaksela na beljakovine.